GOSS
Price
$2.08
Change
+$0.12 (+6.12%)
Updated
Jul 30 closing price
Capitalization
472.79M
12 days until earnings call
MEIP
Price
$5.05
Change
-$0.00 (-0.00%)
Updated
Jul 30 closing price
Capitalization
150.89M
Interact to see
Advertisement

GOSS vs MEIP

Header iconGOSS vs MEIP Comparison
Open Charts GOSS vs MEIPBanner chart's image
Gossamer Bio
Price$2.08
Change+$0.12 (+6.12%)
Volume$3.91M
Capitalization472.79M
MEI Pharma
Price$5.05
Change-$0.00 (-0.00%)
Volume$523.98K
Capitalization150.89M
GOSS vs MEIP Comparison Chart in %
Loading...
GOSS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MEIP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GOSS vs. MEIP commentary
Jul 31, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GOSS is a StrongBuy and MEIP is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 31, 2025
Stock price -- (GOSS: $2.08 vs. MEIP: $5.05)
Brand notoriety: GOSS and MEIP are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GOSS: 155% vs. MEIP: 39%
Market capitalization -- GOSS: $472.79M vs. MEIP: $150.89M
GOSS [@Biotechnology] is valued at $472.79M. MEIP’s [@Biotechnology] market capitalization is $150.89M. The market cap for tickers in the [@Biotechnology] industry ranges from $239.5B to $0. The average market capitalization across the [@Biotechnology] industry is $2.39B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GOSS’s FA Score shows that 0 FA rating(s) are green whileMEIP’s FA Score has 0 green FA rating(s).

  • GOSS’s FA Score: 0 green, 5 red.
  • MEIP’s FA Score: 0 green, 5 red.
According to our system of comparison, MEIP is a better buy in the long-term than GOSS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GOSS’s TA Score shows that 4 TA indicator(s) are bullish while MEIP’s TA Score has 4 bullish TA indicator(s).

  • GOSS’s TA Score: 4 bullish, 3 bearish.
  • MEIP’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, GOSS is a better buy in the short-term than MEIP.

Price Growth

GOSS (@Biotechnology) experienced а +11.23% price change this week, while MEIP (@Biotechnology) price change was -18.55% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.29%. For the same industry, the average monthly price growth was +15.27%, and the average quarterly price growth was +40.33%.

Reported Earning Dates

GOSS is expected to report earnings on Nov 06, 2025.

MEIP is expected to report earnings on May 13, 2025.

Industries' Descriptions

@Biotechnology (-2.29% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GOSS($473M) has a higher market cap than MEIP($151M). GOSS YTD gains are higher at: 129.936 vs. MEIP (105.285). MEIP has higher annual earnings (EBITDA): -22.17M vs. GOSS (-35.7M). GOSS has more cash in the bank: 258M vs. MEIP (20.5M). MEIP has less debt than GOSS: MEIP (11.7M) vs GOSS (203M). GOSS has higher revenues than MEIP: GOSS (125M) vs MEIP (0).
GOSSMEIPGOSS / MEIP
Capitalization473M151M313%
EBITDA-35.7M-22.17M161%
Gain YTD129.936105.285123%
P/E RatioN/A1.09-
Revenue125M0-
Total Cash258M20.5M1,259%
Total Debt203M11.7M1,735%
FUNDAMENTALS RATINGS
GOSS vs MEIP: Fundamental Ratings
GOSS
MEIP
OUTLOOK RATING
1..100
2332
VALUATION
overvalued / fair valued / undervalued
1..100
57
Fair valued
69
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10098
PRICE GROWTH RATING
1..100
3535
P/E GROWTH RATING
1..100
10038
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

GOSS's Valuation (57) in the Pharmaceuticals Major industry is in the same range as MEIP (69) in the Pharmaceuticals Other industry. This means that GOSS’s stock grew similarly to MEIP’s over the last 12 months.

GOSS's Profit vs Risk Rating (100) in the Pharmaceuticals Major industry is in the same range as MEIP (100) in the Pharmaceuticals Other industry. This means that GOSS’s stock grew similarly to MEIP’s over the last 12 months.

MEIP's SMR Rating (98) in the Pharmaceuticals Other industry is in the same range as GOSS (100) in the Pharmaceuticals Major industry. This means that MEIP’s stock grew similarly to GOSS’s over the last 12 months.

MEIP's Price Growth Rating (35) in the Pharmaceuticals Other industry is in the same range as GOSS (35) in the Pharmaceuticals Major industry. This means that MEIP’s stock grew similarly to GOSS’s over the last 12 months.

MEIP's P/E Growth Rating (38) in the Pharmaceuticals Other industry is somewhat better than the same rating for GOSS (100) in the Pharmaceuticals Major industry. This means that MEIP’s stock grew somewhat faster than GOSS’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
GOSSMEIP
RSI
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 1 day ago
84%
Momentum
ODDS (%)
Bullish Trend 1 day ago
81%
N/A
MACD
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 4 days ago
81%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
83%
Bearish Trend 1 day ago
81%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 1 day ago
71%
Advances
ODDS (%)
Bullish Trend 4 days ago
83%
Bullish Trend 7 days ago
72%
Declines
ODDS (%)
N/A
Bearish Trend 3 days ago
81%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 1 day ago
83%
Aroon
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
64%
View a ticker or compare two or three
Interact to see
Advertisement
GOSS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MEIP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PVIVX49.36N/A
N/A
Paradigm Micro-Cap
PFPWX57.19N/A
N/A
Parnassus Value Equity Institutional
MRVNX11.45N/A
N/A
Mirova International Megatrends N
GLEPX13.69-0.01
-0.07%
GS Energy Infrastructure Fd Instl Shares
RAPAX10.77-0.09
-0.83%
Cohen & Steers Real Assets A

MEIP and

Correlation & Price change

A.I.dvisor indicates that over the last year, MEIP has been loosely correlated with GOSS. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if MEIP jumps, then GOSS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MEIP
1D Price
Change %
MEIP100%
N/A
GOSS - MEIP
45%
Loosely correlated
+6.12%
TELO - MEIP
31%
Poorly correlated
-4.39%
AXON - MEIP
28%
Poorly correlated
+2.73%
DNLI - MEIP
27%
Poorly correlated
+0.44%
APM - MEIP
25%
Poorly correlated
+1.84%
More